PARIS | July 27th, 2021 – We are pleased to announce the July edition of our Telemedicine report, focusing on the key highlights from H1 2021. While valuation multiples have stabilized on our global index of listed telemedicine companies, M&A and fundraising in Europe have continued to soar through the first half of 2021. With big tech players entering the space, what can we expect for the future of the industry?
Key Highlights: